Compare AbbVie Inc (ABBV) vs Motorola Solutions Inc (MSI) Price & Performance

AbbVie (ABBV) trades at $247.91, up 0.76% on the day, with strong technical momentum as the stock approaches resistance near $249. The company demonstrates solid fundamentals with Q2 2026 EPS beating expectations at $3.65 versus $3.61, driven by robust immunology portfolio growth from Skyrizi and Rinvoq offsetting Humira declines. Revenue reached $61.16B in 2025 with a 71.48% gross margin, though net income margin compressed to 9.8%. Recent positive Phase 2 ovarian cancer data and institutional accumulation signal confidence in the pipeline.

Outlook remains positive with analyst consensus target of $281.33 (13.5% upside) and 71% buy ratings, though elevated P/E of 70.05 reflects growth expectations. Key risks include patent cliffs in the 2030s, competitive pressures, and regulatory uncertainties from drug pricing lawsuits. The dividend aristocrat offers income stability with recent $1.73 payout, but investors should monitor execution of oncology pipeline and debt levels at 50.4% of assets.

Motorola Solutions (MSI) trades at $467.55, down 1.38% on the day, yet maintains a strong bullish technical trend with moving averages signaling buy. The company reported robust Q2 2026 results, beating EPS estimates with $4.41 versus $3.85 expected, and raised full-year guidance amid record backlog of $15.6 billion. Revenue grew 13% year-over-year, driven by demand in public safety communications and software services. Valuation ratios remain elevated, with a P/E of 36.84 and P/S of 6.42, reflecting premium pricing for its growth trajectory.

Outlook is positive with analyst consensus price target of $533.80 implying 14% upside, supported by strong fundamentals and institutional accumulation. Key risks include execution challenges to meet raised guidance, high valuation sensitivity to earnings misses, and macroeconomic pressures on public sector spending. The stock's current level near pivot point resistance at $471 requires monitoring for breakout confirmation.